Enzymatic degradation of heparin-modified hydrogels and its effect on bioactivity

Biomaterials
Anastasia NilasaroyaJohn M Whitelock

Abstract

The extracellular matrix is continually remodelled by the action of various enzymes such as heparanase, which specifically targets heparan sulfate (HS) and is found in human platelets at high levels. The activity of heparin-containing hydrogels following incubation with platelet extract (PE) was investigated in order to simulate the responses that might occur when the hydrogels, as tissue engineered scaffolds, come in contact with blood products at the site of an injury. The heparanase activity of PE on heparin, used as a model of HS, was confirmed by the decrease in molecular weight. PE treatment diminished heparin's anticoagulation property but increased its FGF-2 signalling activity, suggesting that the PE's heparanase activity cleaves at the 3-O-sulfated glucosamine to produce large fragments that can signal cell receptors. The dual effect observed when poly(vinyl alcohol)/heparin co-hydrogels were incubated with PE supports the hypothesis of platelets having the capacity to limit anticoagulation and thus promote blood clot formation, which may be critical in the process of tissue repair.

References

Feb 28, 1979·Biochemical and Biophysical Research Communications·R D RosenbergL H Lam
Jul 1, 1997·The Biochemical Journal·C Freeman, C R Parish
May 23, 1998·The Biochemical Journal·C Freeman, C R Parish
Jul 21, 1998·The Journal of Biological Chemistry·D S PikasU Lindahl
Aug 19, 2003·Biomaterials·Jeanie L Drury, David J Mooney
Aug 21, 2003·Analytical Biochemistry·Farhad Behzad, Paul E C Brenchley
Nov 25, 2003·The Journal of Biological Chemistry·Jane ReilandDario Marchetti
Aug 13, 2004·Cardiovascular Research·Amit SegevBradley H Strauss
Nov 10, 2004·Matrix Biology : Journal of the International Society for Matrix Biology·Ralph D SandersonThomas Kelly
Mar 12, 2005·The Journal of Biological Chemistry·Flonia Levy-AdamNeta Ilan
Jul 14, 2005·Chemical Reviews·John M Whitelock, Renato V Iozzo
Feb 8, 2006·Journal of Thrombosis and Haemostasis : JTH·N J NasserI Vlodavsky
Sep 22, 2007·Biomacromolecules·Martin EhrbarMatthias P Lutolf
Feb 19, 2008·The Journal of Biological Chemistry·Sarah J GoodgerJohn T Gallagher
Sep 19, 2008·Biomaterials·Anastasia NilasaroyaPenny Jo Martens
Oct 2, 2008·Biochemistry·John M WhitelockRenato V Iozzo

❮ Previous
Next ❯

Citations

Jan 29, 2014·Analytical Chemistry·Yanbin CaiZhimou Yang
Oct 15, 2013·Acta Biomaterialia·Tobias MillerJohnna S Temenoff
May 28, 2015·Journal of Biomedical Materials Research. Part a·Eman H NafeaPenny J Martens
Oct 6, 2016·Expert Opinion on Drug Delivery·Dunyin GuKatharina Ladewig
Jun 10, 2020·Journal of Biomedical Materials Research. Part a·Anastasia NilasaroyaDavid Anthony Morrison
Apr 8, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Josef GodingRylie Green

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Matrix Biology : Journal of the International Society for Matrix Biology
Sherket B Peterson, Jian Liu
Matrix Biology : Journal of the International Society for Matrix Biology
Benito CasuGiangiacomo Torri
Critical Reviews in Biochemistry and Molecular Biology
S ErnstR Sasisekharan
© 2021 Meta ULC. All rights reserved